Cancer is an abnormal condition leading to uncontrolled cell division which causes damage
to the body tissues. Around 100 types of cancer are studied so far namely breast cancer …

Nanoparticle drug delivery systems have proved anti-tumor effects; however, they are not
widely used in tumor therapy due to insufficient ability to target specific sites, multidrug …

Aggressive and recurrent gynecological cancers are associated with worse prognosis and a
lack of effective therapeutic response. Ovarian cancer (OC) patients are often diagnosed in …

Hepatocellular carcinoma (HCC) continues to be a leading cause of cancer related death in
the world. Conventional chemotherapeutic agents such as cisplatin (CDDP) have an …

Thioacetal/thioketal moieties have been identified as responsive to reactive oxygen species
(ROS). Despite its utility in a broad range of applications, the mechanism that underlies the …

Berberine (BBR) is an isoquinoline alkaloid belonging to the structural class of
protoberberines. BBR has been used in traditional medicine to treat diseases, such as type …

The synthesis and the evaluation of the efficacy of a cycloruthenated complex, RuZ, is
reported, to overcome multi‐drug resistance (MDR) in cancer cells. RuZ can self‐assemble …

The enhanced endo-lysosomal sequestration still remains a big challenge in overcoming
multidrug resistance (MDR). Herein, a dual-responsive polyplex with effective endo …

Recently DNA aptamers have attracted remarkable attention as possible targeting ligands
since selective targeting of cancer cells is a critical step in cancer diagnosis and therapy …

Combination nanodrugs are promising therapeutic agents for cancer treatment. However,
they often require the use of complex nanovehicles for transportation into the tumor site …